PVI
ALXN

Pura Vida Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Pura Vida Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-30,000
Closed -$3.34M – 121
2018
Q1 		$3.34M Buy
+30,000
New +$3.59M 1.98% 20
2016
Q3 		– Sell
-37,500
Closed -$4.38M – 104
2016
Q2 		$4.38M Buy
+37,500
New +$5.32M 1.86% 19

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Pura Vida Investments's ALXN Position: Q2 2021 in Review

Pura Vida Investments sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 156,581 shares — an estimated $23.9M sold.

Pura Vida Investments first reported a position in ALXN in Q4 2014 and held it in 23 quarters. The position peaked at $23.9M in Q1 2021. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Pura Vida Investments reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 156,581 Alexion Pharmaceuticals shares in Q2 2021, an estimated $23.9M.
  • Pura Vida Investments first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 23 quarters.
  • Pura Vida Investments's Alexion Pharmaceuticals position peaked at $23.9M in Q1 2021.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.